[go: up one dir, main page]

CL2013003435A1 - Process of preparation of estetrol intermediaries using palladium catalysts and acylating or silylating protecting groups; and use of said process to prepare estetrol. - Google Patents

Process of preparation of estetrol intermediaries using palladium catalysts and acylating or silylating protecting groups; and use of said process to prepare estetrol.

Info

Publication number
CL2013003435A1
CL2013003435A1 CL2013003435A CL2013003435A CL2013003435A1 CL 2013003435 A1 CL2013003435 A1 CL 2013003435A1 CL 2013003435 A CL2013003435 A CL 2013003435A CL 2013003435 A CL2013003435 A CL 2013003435A CL 2013003435 A1 CL2013003435 A1 CL 2013003435A1
Authority
CL
Chile
Prior art keywords
estetrol
silylating
intermediaries
acylating
prepare
Prior art date
Application number
CL2013003435A
Other languages
Spanish (es)
Inventor
Jean-Claude Pascal
Original Assignee
Estetra Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65657112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013003435(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Estetra Sprl filed Critical Estetra Sprl
Publication of CL2013003435A1 publication Critical patent/CL2013003435A1/en

Links

CL2013003435A 2011-06-01 2013-11-29 Process of preparation of estetrol intermediaries using palladium catalysts and acylating or silylating protecting groups; and use of said process to prepare estetrol. CL2013003435A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161492300P 2011-06-01 2011-06-01
EP11168561 2011-06-01

Publications (1)

Publication Number Publication Date
CL2013003435A1 true CL2013003435A1 (en) 2014-08-01

Family

ID=65657112

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003435A CL2013003435A1 (en) 2011-06-01 2013-11-29 Process of preparation of estetrol intermediaries using palladium catalysts and acylating or silylating protecting groups; and use of said process to prepare estetrol.

Country Status (1)

Country Link
CL (1) CL2013003435A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11452733B2 (en) 2018-04-19 2022-09-27 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
US11484539B2 (en) 2018-04-19 2022-11-01 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
US11896602B2 (en) 2016-08-05 2024-02-13 Estetra Srl Method for preventing pregnancy
US11964055B2 (en) 2015-06-18 2024-04-23 Estetra Srl Orodispersible dosage unit containing an estetrol component
US12458649B2 (en) 2020-04-16 2025-11-04 Estetra Srl Contraceptive compositions with reduced adverse effects

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11964055B2 (en) 2015-06-18 2024-04-23 Estetra Srl Orodispersible dosage unit containing an estetrol component
US11896602B2 (en) 2016-08-05 2024-02-13 Estetra Srl Method for preventing pregnancy
US11452733B2 (en) 2018-04-19 2022-09-27 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
US11484539B2 (en) 2018-04-19 2022-11-01 Estetra Sprl Compounds and their uses for alleviating menopause-associated symptoms
US11666585B2 (en) 2018-04-19 2023-06-06 Estetra Srl Compounds and their uses for alleviating menopause-associated symptoms
US12390478B2 (en) 2018-04-19 2025-08-19 Estetra Srl Compounds and their uses for alleviating menopause-associated symptoms
US12458651B2 (en) 2018-04-19 2025-11-04 Estetra Srl Compounds and their uses for alleviating menopause-associated symptoms
US12458649B2 (en) 2020-04-16 2025-11-04 Estetra Srl Contraceptive compositions with reduced adverse effects

Similar Documents

Publication Publication Date Title
CO6831975A2 (en) Immunoconjugates, compositions to prepare them, methods to prepare them and use
BR112014005746A2 (en) engineered fabrics for in vitro research use, arrangement thereof, and methods of manufacturing the same
BR112015013440A2 (en) compositions comprising steric cyclic purine dinucleotides and defined methods for their preparation and use
BR112015013722A2 (en) adaptive armrest systems and methods for use
CO6870005A2 (en) Anti-cgrp composition and use thereof
IL248607A (en) Methods and preparations for vaccination against virus
HUE052406T2 (en) Optimization and use of antibodies that bind to lymphocyte activation gene-3 (LAG-3)
CO7020870A2 (en) Anti-htra1 antibodies and methods of use
BR112013033466A8 (en) use of a controlled release system and controlled release system
BR112014009837A2 (en) Effective use of yeast and yeast extract
BR112013012969A2 (en) fatigue rates and uses for them
ZA201404797B (en) Influenza virus vaccines and uses thereof
IL231547A0 (en) Influenza virus vaccines and uses thereof
CO7000747A2 (en) Anti-lrp5 antibodies and methods of use
CL2014001628A1 (en) Methods for purifying ateviol glycosides; compositions and uses thereof
BR112014010175A2 (en) filter units, components and features of these, and methods of use and construction
CO7020865A2 (en) Microorganisms and methods to produce alkenes
BR112014012590A2 (en) anti-cd98 antibodies and methods of use
CL2015001266A1 (en) Antihemagglutinin antibodies and methods of use.
BR112014010538A2 (en) filter article and exhaust gas treatment system
BR112014005406A2 (en) vaccine composition and its use
BR112014002716A2 (en) anti-polyubiquitin antibodies and methods of use
CO6940436A2 (en) Composition of phyto-disease control and its use
BR112013034055A2 (en) alcaftadine for use in the treatment of urticaria
CL2013002581A1 (en) Compounds derived from indole-and -benzimidazole carboxamides; Procedure to prepare them; use of said compounds to produce pesticides; and intermediary compounds.